NORTH CHICAGO, Ill., Nov. 2, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Credit Suisse 24th Annual Healthcare Conference on Wednesday, Nov. 11, 2015. Richard A. Gonzalez, chairman and chief executive officer, will participate in a question and answer session at 11 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-credit-suisse-24th-annual-healthcare-conference-300170316.html
SOURCE AbbVie
Media, Adelle Infante, (847) 938-8745; Investors: Liz Shea, (847) 935-2211
